Skip navigation

Developing Compliance Solutions to Anticipate Regulation and Minimize Risk

October 16, 2017
  • San Francisco, CA

Forward thinking pharmaceutical and biotech companies will minimize their vulnerability and ensure market success through compliant program delivery and related marketing and promotion. Explore the topography of tomorrow’s regulatory landscape while focusing on practical solutions to today’s challenges.

At CBI’s Compliant Patient Support Programs West, manufacturers, service providers and other influential stakeholders are given the opportunity to learn about the changing regulatory landscape of patient program compliance. Leaders in the industry have begun to anticipate the inevitability of federal regulation and are taking proactive steps to move towards a compliant framework.


  • Recent Legal Action and OIG Advisory Opinions
  • Risks Within Closed Versus Open Distribution Networks
  • Strategies to Safeguard PAP Performance
  • High and Low Risk Programs Commonly Found Within the Hub Structure
  • Ensure Compliant Message Delivery with Patient Advocates
  • Overcome Regulatory and Ethical Issues Associated with
    Emerging Social Channels
  • Guidance on Auditing 501(C)(3) Partnerships to Realize Maximum Utility

Previous Attendee Acclaim:

A great platform to address important industry-related topics and to connect with likeminded professionals.

Senior Manager, Patient Support Programs, Gilead

The subject matter and speakers were right on target and very helpful in guiding me in designing our programs.

Patient Experience Lead, UCB